Presented at the Arthritis Advisory Committee meeting on July 15, 2003 by Hugh Davies, M.D.

Slides:



Advertisements
Similar presentations
Booking & Choice Colin Innes Executive Lead Choose and Book.
Advertisements

Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
The HPSS Research Ethics Service Northern Ireland Dr Siobhan McGrath Office for Research Ethics Committees Northern Ireland Mar2007.
Research Policy & Management RACD INTRODUCTION TO RESEARCH GOVERNANCE.
Honorary Research Contracts and the Research Passport Julia Miller Assistant Director of Research and Development NW SHA.
Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB
Research involving adults lacking the capacity to consent Legal, ethical and practical issues Dr Mikey Dunn Senior Research Associate in Health and Social.
R&D Directorate Difference between Research and Clinical Audit
An Introduction to the Ethics Review Procedure Lindsay Unwin: Research & Innovation Services, UREC Secretary.
Using IFRS Based Financial Statements In Corporate Governance Gareth Davies Local Authority (Scotland) Accounts Advisory Committee secretary CIPFA Policy.
Ethics Approval for Projects based overseas George Ellison (Director) Research & Graduate School
0 This document is CONFIDENTIAL and its distribution and use are RESTRICTED © 2012 KPMG LLP, a UK limited liability partnership and a member firm of the.
Development of internal control: methodology and responsibility
Update: Operational Delivery Networks Denise McLellan Transitional Lead, Networks and Senates, Midlands and East November 2012.
Professor Ian Anderson & Ms Debra Knoche Centre for Health & Society – Onemda VicHealth Koori Health Unit University of Melbourne National Workforce Strategy.
Liability in Clinical Research Clinical Effectiveness Unit Division, PS & MD 2005 Liability in Clinical Research Clinical Effectiveness Unit Division,
Managing Sponsorship Research Services University of Oxford.
Research ethics in The Netherlands dr Annelien Bredenoord & prof dr Hans van Delden UMC Utrecht Julius Center The Netherlands
Research Ethics-Integrity-Governance. University Initiative:The Catalyst? ‘02 Good Research Practice Standards & Procedure to Investigate Potential Research.
Keele, 20/07/10 Heike Schmidt-Felzmann Centre of Bioethical Research and Analysis National University of Ireland, Galway Research Ethics in Ireland COBRA.
Module 2 Sealy Center on Aging What kinds of scholarly products can I produce?
Consultant Pharmacists
Applying to a Research Ethics Committee
The Chief Scientist Office. Developments/Restructuring Of Research Funding In Scotland Overview of NHS Infrastructure funding ( ) What we have.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Summary About me & AMRC About the EU Clinical Trials Regulation – what’s new Implementation timeline What does this mean for UK ethicists?
Research, Ethics, Governance: the evolving regulatory landscape Jonathan Montgomery Professor of Healthcare Law, University of Southampton Chair, Health.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Professor R Endacott Professor R Sheaff Professor R Jones Dr V Woodward.
Retha Britz Copyright 2013 All rights reserved for this presentation 1 Establishment and functioning of a REC Retha Britz.
Embedding a Broader Needs Assessment
Central Office for Research Ethics Committees (COREC) New system for Research Ethics Committees Sure Start – April 2004 Joan Kirkbride OREC Manager for.
Trials Registration An Ethical Perspective Michael Goodyear 1, Lisa Golec 2 1. Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie.
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
1 Research Governance in Social Care Where to next? Paul Dolan,Birmingham City Council SSRG Annual Workshop, Manchester 2008.
XXX_DECRIPT_MON00/1 Quality and impact of Social Science and Operations Research by the Special Programme in Human Reproduction Department of Reproductive.
ANZ Clinical Trials - What is the Future? Session Chair: Michael Quinn.
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Department of Health and Human Services Office of the Assistant Secretary for Health (ASH) Advisory Committee on Blood Safety and Availability (ACBSA)
Engaging Communities and the Workforce through Co-production Gerry Power National Lead – Coproduction and Community Capacity Building Shifting the Focus.
THE ROLE OF DSMB’s in CLINICAL RESEARCH Data and Safety Monitoring Monitoring.
ENT, OMF and Head and Neck Cancer Services Review Mary Hutton 27 th January 2011.
R&D – a perspective Dr Nana Theodorou Research Coordinator Sheffield Clinical Research Office.
West Midlands (South) Comprehensive Local Research Network NIHR Governance Systems Regimantas Pestininkas Deputy Research Governance Manager 1 July 2010.
Age & Disabilities Odyssey Conference Tuesday, June 21, 2011.
Disability Service Provision A Perspective from the Department of Health and Children Fergal Lynch Assistant Secretary, Continuing Care Policy 14 November.
Legal aspects of Health Data protection Solvita Olsena Medical Law Institute Ltd.
Applicability of principles Reidar K. Lie, MD, PhD Department of Clinical Bioethics, NIH and University of Bergen, Norway.
Challenges of 21st Century Clinical Research from an Independent IRB’s View Chesapeake Research Review, Inc. Paul Goebel, CIP Vice President Matthew Whalen,
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
Accessing the NHS for Research – NHS R&D Permissions Jemma Hughes R&D Manager ABMU Health Board.
Nottingham Trent University Alternative Futures Conference 2014 The OECD concept of the ‘Strategic State’ and its application to 3 inter-related areas.
Ombudsman Western Australia Serving Parliament – Serving Western Australians Evaluation in the Western Australian Ombudsman’s Office Kim Lazenby & Jane.
Ethical issues with the regulatory use of gene expression data Benjamin S Wilfond MD Medical Genetics Branch National Human Genome Research Institute Department.
HA Central Register of Clinical Research 1 Dec 04 HA REC.
Grant Writing: Specific Considerations in Clinical Studies Ravi Retnakaran MD MSc FRCPC Leadership Sinai Centre for Diabetes, Mount Sinai Hospital University.
Overcoming challenges in pediatric oncology product development: Regulatory oversight of multi-national clinical studies Ursula Kern, Advisory Committees.
8 th November 2007 Research: ethics and research governance Rossana Dowsett Research and Regional Development Division [Pre Award Support] University of.
AssessPlanDo Review QuestionYesNo? Do I know what I want to evaluate and why? Consider drivers and audience Do I already know the answer to my evaluation.
Off-label Use.
Our Ethical Review Process
A capacity building programme for patient representatives
Background: Need for a national body international development
CPRD: An introduction to the Clinical Practice Research Datalink in Cambridge Rupert Payne.
Research for all Sharing good practice in research management
ICTMS Communicating Trial Results to participants
Chapter 7 Corporate governance and social responsibility
Ethical Theories and Principles in Clinical and Research
Presentation transcript:

Presented at the Arthritis Advisory Committee meeting on July 15, 2003 by Hugh Davies, M.D.

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK KEY WORDS / ABBREVIATIONS REC - Research Ethics Committee MREC - Multi centre Research Ethics Committee LREC - Local Research ethics Committee COREC -- Central Office for Research Ethics Committee UKCCSG – United Kingdom Children’s Cancer Study Group GAfREC – Governance Arrangements for Research Ethics Committees

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK GENERAL PRINCIPLES “The Department of Health requires that all research falling within certain categories is reviewed independently to ensure it meets the required ethical standards” Governance Arrangements for Research ethics Committees 2001

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK THE ETHICAL REVIEW OF RESEARCH Review is undertaken by RESEARCH ETHICS COMMITTEES Their support and management structure is overseen by the CENTRAL OFFICE FOR RESEARCH ETHICS COMMITTEES.

POLICY: the remit of government ETHICS: the remit of RECs ETHICAL REVIEW OF RESEARCH IN THE UK PROCESS: the remit of COREC

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK PAEDIATRIC ONCOLOGY: Specific considerations Single site studies (e.g. a children’s hospital) – Phase I and II studies Multi centre paediatric oncology studies – (eg UKALL)

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK THE TRENT MREC AND THE UKCCSG A close working relationship that has benefits for both reviewer and researcher. In this complex and ethically challenging area, content expertise is essential. UKCCSG has been able to obtain approval for their methodology; subsequent application for individual research projects is greatly facilitated.

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK THE TRENT MREC AND UKCCSG This relationship must be handled carefully. “How close can you sup with the devil?” Everyone needs to be on their moral guard

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK MODELS OF ETHICAL ANALYSIS I would cautiously suggest that the MREC adopts a utilitarian, rather than duty based approach. They are very conscious of the need of paediatric oncology research despite the ethical difficulties

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK TRIAL MONITORING GAfREC “Other than by means of these required reports, the REC has no responsibility for pro-active monitoring of research, the accountability lies with the host NHS institution.” The European Clinical Trials Directive A more uniform approach on the basis of monitoring commensurate with the trial’s complexity and level of risk.

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK INTERNATIONAL COLLABORATION No specific arrangements. No reciprocal arrangements with USA or mainland Europe. RECs are specifically charged to review all aspects of a research project Problems for international studies “Ethical imperialism” or “The EMEA/FDA insists”

APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UNTIDIED KINGDOM CONCLUSIONS

POLICY PROCESS ETHICS APPROVAL OF CLINICAL STUDIES INVOLVING CHILDREN IN THE UK